Howard, Barbara V.

Non-HDL Cholesterol as a Predictor of Cardiovascular Disease in Type 2 Diabetes

Lu, W., Resnick, H. E., Jablonski, K. A., Jones, K. L., Jain, A. K., Howard, W. J., Robbins, D. C., & Howard, B. V. (2003) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

Cited by 370

Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors

Howard, B. V., Best, L. G., Galloway, J. M., Howard, W. J., Jones, K., Lee, E. T., Ratner, R. E., Resnick, H. E., & Devereux, R. B. (2006) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 180

Adiponectin and Coronary Heart Disease: The Strong Heart Study

Lindsay, R. S., Resnick, H. E., Zhu, J., Tun, M. L., Howard, B. V., Zhang, Y., Yeh, J., & Best, L. G. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology

Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and Adiposity

Cited by 169

Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study)**The views expressed here are those of the authors and do not necessarily reflect those of the Indian Health Service.

Chinali, M., Devereux, R. B., Howard, B. V., Roman, M. J., Bella, J. N., Liu, J. E., Resnick, H. E., Lee, E. T., Best, L. G., & de Simone, G. (2004) · The American Journal of Cardiology

Cardiovascular Function and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 157

Metabolic syndrome and coronary angiographic disease progression: the Women’s Angiographic Vitamin & Estrogen trial

Hsia, J., Bittner, V., Tripputi, M., & Howard, B. V. (2003) · American Heart Journal

Menopause: Health Impacts and TreatmentsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 43